Matches in Wikidata for { <http://www.wikidata.org/entity/Q99957473> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q99957473 description "clinical trial" @default.
- Q99957473 description "ensayo clínico" @default.
- Q99957473 description "ensayu clínicu" @default.
- Q99957473 description "klinisch onderzoek" @default.
- Q99957473 description "клінічне випробування" @default.
- Q99957473 description "临床试验" @default.
- Q99957473 name "A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer" @default.
- Q99957473 name "A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer" @default.
- Q99957473 type Item @default.
- Q99957473 label "A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer" @default.
- Q99957473 label "A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer" @default.
- Q99957473 prefLabel "A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer" @default.
- Q99957473 prefLabel "A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer" @default.
- Q99957473 P1132 Q99957473-6EC3358F-CD1E-45A3-BB2D-F89BDC812B27 @default.
- Q99957473 P1476 Q99957473-D65423C2-C5FB-4267-987B-9E22CF9E426B @default.
- Q99957473 P1813 Q99957473-CBDD7355-2C5F-43E4-A2D3-868EA73976F0 @default.
- Q99957473 P2899 Q99957473-E23200C8-4AFD-4DD3-859F-24545DB628CC @default.
- Q99957473 P3098 Q99957473-BA1F91B5-C42D-423F-9A5A-0354B0762EB0 @default.
- Q99957473 P31 Q99957473-671810B0-721C-49D7-9385-CE4724F2803A @default.
- Q99957473 P4844 Q99957473-02822D3A-5B86-481C-BBE5-08A3E047E5BA @default.
- Q99957473 P4844 Q99957473-2B702B00-E241-49CB-87CD-89F97EF77E76 @default.
- Q99957473 P4844 Q99957473-5B3B714E-5D37-45B3-81B2-29C0872386E1 @default.
- Q99957473 P4844 Q99957473-902B29F7-36BF-416E-9B6A-A08C3258D500 @default.
- Q99957473 P4844 Q99957473-A4D9C4EF-4DE2-444F-8FE6-8710001A517A @default.
- Q99957473 P4844 Q99957473-C2F9102C-5783-4B87-9EA9-DB3CD6CB7E36 @default.
- Q99957473 P580 Q99957473-BB21443D-BE2A-4684-B211-20CCB26266B6 @default.
- Q99957473 P582 Q99957473-A7ECD841-F6FE-49F9-9E0B-90D2D88B7D05 @default.
- Q99957473 P6099 Q99957473-9A887B75-CC07-4AB6-AF61-B13142D0FF3A @default.
- Q99957473 P8005 Q99957473-70D66E9D-2C7B-4309-9E35-3C528B54CB0C @default.
- Q99957473 P8363 Q99957473-36918A2F-41D3-4348-8A4E-FA579AFD9F3D @default.
- Q99957473 P859 Q99957473-96454D1D-BC45-4D05-B0E3-4EC6EFA82731 @default.
- Q99957473 P1132 "+185" @default.
- Q99957473 P1476 "A Phase 1b Multicentre, Open-label, Modular, Dose-finding and Dose-expansion Study to Explore the Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of Trastuzumab Deruxtecan (T-DXd) in Combination With Other Anti-cancer Agents in Patients With Metastatic HER2-low Breast Cancer (DESTINY-Breast08)" @default.
- Q99957473 P1813 "DB-08" @default.
- Q99957473 P2899 "+18" @default.
- Q99957473 P3098 "NCT04556773" @default.
- Q99957473 P31 Q30612 @default.
- Q99957473 P4844 Q19904005 @default.
- Q99957473 P4844 Q412616 @default.
- Q99957473 P4844 Q419143 @default.
- Q99957473 P4844 Q420207 @default.
- Q99957473 P4844 Q423762 @default.
- Q99957473 P4844 Q5508491 @default.
- Q99957473 P580 "2020-11-27T00:00:00Z" @default.
- Q99957473 P582 "2022-12-23T00:00:00Z" @default.
- Q99957473 P6099 Q5452194 @default.
- Q99957473 P8005 Q76649614 @default.
- Q99957473 P8363 Q78089383 @default.
- Q99957473 P859 Q731938 @default.